# ImmunityBio, Inc.

> Developing immune system therapeutics

Business model and tags: B2B, Publicly traded, Pharma & life sciences, Has in-house R&D

## About ImmunityBio, Inc.

Developing innovative cell and immunotherapy products to strengthen the immune system, target cancer and infectious diseases, and create immunological memory for long-term defense

## Key facts

- **Industry**: Biotechnology Research
- **Company size**: 251–1,000 employees
- **Headquarters**: san diego, california, United States
- **Founded**: 2014
- **Revenue**: $113M (FY2025, publicly reported)
- **Website**: [immunitybio.com](https://immunitybio.com/)
- **LinkedIn**: [linkedin.com/company/immunitybio](https://www.linkedin.com/company/immunitybio)

## ImmunityBio, Inc. at a glance

ImmunityBio, Inc. is a B2B company in the Biotechnology Research industry, headquartered in san diego, california, United States.

ImmunityBio, Inc. was founded in 2014.

ImmunityBio, Inc. has 251–1,000 employees.

ImmunityBio, Inc.'s revenue is $113M (FY2025, publicly reported).

## Frequently asked questions about ImmunityBio, Inc.

### What is ImmunityBio, Inc.'s revenue?

ImmunityBio, Inc.'s revenue is $113M (FY2025, publicly reported).

### How many employees does ImmunityBio, Inc. have?

ImmunityBio, Inc. has 251–1,000 employees.

### Where is ImmunityBio, Inc. headquartered?

ImmunityBio, Inc. is headquartered in san diego, california, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/immunitybio-inc
